Dr. Durdin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1904 Pine St
Ste 3A
Abilene, TX 79601Phone+1 325-670-6180Fax+1 833-437-1278
Summary
- Urologic Oncologist serving the cancer needs of West Texas
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2020 - 2022
Texas A&M College of Medicine-Scott and White Medical Center (Temple)Residency, Urology, 2015 - 2020
Texas Tech University Health Sciences Center School of MedicineClass of 2015
Texas A&MB.S., Biomedical Science, 2007 - 2011
Certifications & Licensure
NY State Medical License 2019 - 2025
TX State Medical License 2018 - 2025
Publications & Presentations
PubMed
- 5 citationsCan an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer?Trey Durdin, Alvin C. Goh, Eugene J. Pietzak
European Urology. 2021-04-08 - 29 citationsNeoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.Samuel A Funt, Michael Lattanzi, Karissa Whiting, Hikmat Al-Ahmadie, Colleen Quinlan
Journal of Clinical Oncology. 2022-04-20 - 3 citationsPreoperative ureteral stenting prior to ureteroscopy for management of urolithiasis does not impact the postoperative return for unplanned care.Andrew F. Navetta, Amr Elmekresh, Karen M. Doersch, Trey D. Durdin, G. Luke Machen
Urology Annals. 2019-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
